Palla Pharma to pay $1.125M to settle lawsuit over codeine poppy patents
Intellectual Property 2019-06-27 11:57 am By Cat Fredenburgh | Melbourne
Please login to bookmark Close

Poppy processor Palla Pharma has agreed to pay $1.125 million to rival Tasmanian Alkaloids t0 settle a lawsuit alleging infringement of two innovation patents for high codeine-concentrated poppy.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au